Heroin addiction changes the body, the mind, and the life around it.

Heroin addiction is a chronic opioid use disorder characterised by compulsive drug-seeking, progressive tolerance, and physiological dependence. The signs accumulate differently in different people. A long-term street user and a professional who transitioned from prescription opioids to heroin may present with few of the same visible indicators, yet both are experiencing the same underlying clinical process.

The signs are what bring most people to assessment, not a formal diagnosis they arrive with. At Jintara, the admissions process starts with a psychiatrist-led assessment that uses the Clinical Opiate Withdrawal Scale (COWS) alongside a thorough substance use history to establish dependence severity objectively. Families do not need to arrive with a diagnosis. The clinical team establishes that on day one, drawing on NIDA's overview of heroin addiction and standard diagnostic criteria.

Understanding what to look for begins with knowing that no single sign is diagnostic on its own. The pattern matters more than any individual symptom. Physical signs, behavioural changes, and psychological shifts each reveal a different part of the picture, and seeing all three is what makes a clinical assessment useful.

The most immediately visible physical sign of heroin use is constricted pupils, sometimes described as pinpoint pupils, that occur even in low-light conditions. Alongside this, sedation, slowed breathing, and a nodding-off pattern during normal activity are consistent signs of active use. People may slur words, lose track of conversations, or seem to fall asleep mid-sentence.

With intravenous use, track marks appear along veins, most commonly in the forearm, but also in the leg, groin, neck, or foot when more visible sites have collapsed. Abscesses, bruising, and infection at injecting sites are common complications of repeated IV use, and the CDC's guidance on blood-borne pathogen risk from injection drug use confirms the range of infection risks that accompany needle use. Skin popping, the practice of injecting under the skin rather than into a vein, produces distinctive scarring patterns.

Other physical signs include significant weight loss as appetite decreases, deteriorating dental health, persistent runny nose or sniffling in users who smoke or snort heroin, and a general decline in physical appearance and hygiene that develops gradually over months of use.

The physical withdrawal process that begins within hours of a missed dose is itself a set of recognisable signs. Muscle cramps, sweating, goosebumps, nausea, vomiting, and agitation that clear rapidly when a dose is taken are a reliable indicator that dependence has established. Physical recovery from these symptoms is one of the most difficult parts of early treatment, which is why structured holistic recovery support alongside medical detox matters in the first weeks. Nursing staff monitor these withdrawal signs continuously so that discomfort is managed rather than endured alone.

Behavioural changes are often noticed by family members and colleagues before the individual is willing to acknowledge a problem. Social withdrawal is one of the earliest consistent patterns: fewer outings, cancelled commitments, and a growing preference for being alone or with a smaller and smaller social group. Secretive behaviour around phones, money, and whereabouts intensifies as use escalates.

People in this stage often describe feeling like they are managing fine, until something interrupts supply. Seeing what the first week looks like at Jintara shows how quickly the clinical picture shifts once a structured setting replaces that day-to-day management effort, and how much of the effort was going into concealment rather than living. That shift is often the first time the person sees the full pattern for what it is.

Reliability deteriorates. Deadlines are missed, appointments are forgotten, and responsibilities that were previously managed without difficulty start to slip. In a work context this may appear initially as reduced performance rather than absence. At home it presents as disengagement, irritability, and an inability to tolerate the ordinary demands of daily life.

Financial strain emerges even when income is significant. Heroin is expensive when purchased daily, and escalating tolerance means that costs increase over time. Unexplained withdrawals, money going missing, or a sudden pattern of borrowing without repayment are patterns families describe in retrospect as the signs they dismissed at the time.

Craving, compulsion, and failed attempts to stop are the psychological hallmarks of heroin addiction, and they are the signs most commonly dismissed by loved ones as choices rather than symptoms. In most cases they travel alongside co-occurring mental health conditions such as depression, anxiety, and trauma, which is why Jintara assesses both from the first days of treatment rather than treating them as separate problems. NIDA's DrugFacts on heroin outlines how these hallmarks meet the diagnostic criteria for heroin use disorder under DSM-5.

Failed attempts to stop are one of the diagnostic criteria for heroin use disorder. Most people in the middle of active heroin addiction have attempted to stop at least once and found it either impossible or sustainable only for a short period before relapse. The cycle of stopping, withdrawing, briefly feeling that it is manageable, and then using again reinforces both the physical dependence and the belief that change is not possible.

The person is not choosing the drug over the people they love. They are responding to a neurological signal that has become the dominant organising force in their decision-making, and craving in this context is a symptom rather than a lack of willpower.

Continued use despite serious consequences, damaged relationships, job loss, health deterioration, or legal risk, is perhaps the most consistently misunderstood sign. Families often interpret this as a choice, or as evidence that the person does not care. It is neither. It is the defining feature of a disorder that has compromised the brain's capacity for long-range consequence evaluation.

The picture of heroin addiction most people carry is informed by extreme cases: visible deterioration, homelessness, or severe health decline. That picture is real and clinically significant. It is not, however, representative of all heroin addiction, and it is particularly unrepresentative of the population that reaches private residential treatment.

A substantial proportion of Jintara's admissions are professionals aged 25 to 65 who have managed a substance use problem alongside a career, a family, and a social identity for months or years. Many arrived at heroin through prescription opioid use that was initially legitimate, then escalated beyond clinical guidance, and then transitioned to street heroin when prescriptions became unavailable or insufficient.

The signs in this population are present but more internal: a private anxiety around access, a consistent pattern of use that the person organises their day around, tolerance that makes normal functioning feel impossible without the drug, and escalating fear of withdrawal that makes cessation feel more dangerous than continuation.

This framing matters at the admissions stage because many high-functioning users dismiss their own signs as evidence they do not have a real problem. The clinical assessment at Jintara does not require a threshold of visible decline. What it requires is an honest account of use, and the treatment program at Jintara is built around exactly this population, establishing severity from that history rather than from appearance. Many high-functioning clients are surprised to find their private, internal signs are precisely what the intake is designed to hear.

Heroin produces its effects by binding to opioid receptors in the brain, suppressing pain signals, and triggering a dopamine release that creates intense euphoria in early use. For many people the escalation is driven by underlying trauma, and trauma-focused therapy at Jintara addresses that root alongside the physical dependence. The brain adapts to the drug rapidly, and within weeks to months of regular use, the same dose produces less effect, so more of the drug is needed to achieve the original result, and then more again.

This tolerance mechanism is not a sign of weak character. It is a pharmacological process that occurs in the same way in every brain exposed to opioids at sufficient frequency and dose. As SAMHSA's clinical guidance on opioid use treatment documents, the speed of tolerance development varies by individual but the direction is consistent: up.

The clinical consequence is that users who started on a dose they could manage eventually find themselves dependent on amounts that create serious overdose risk if the source or purity changes, or that create severe withdrawal symptoms if the supply is interrupted. Street heroin varies significantly in purity, and a person returning to use after a period of abstinence who takes their previous dose risks respiratory depression because their tolerance has dropped.

Heroin overdose occurs when the drug suppresses the respiratory drive to the point that breathing slows and stops. It is a medical emergency. The signs of heroin overdose are unresponsiveness, very slow or stopped breathing, choking or gurgling sounds, blue or purple lips and fingernails, and pinpoint pupils in an unconscious person. If you are witnessing these signs, call emergency services immediately.

Overdose risk increases substantially in several predictable circumstances. After a period of enforced abstinence, whether through hospitalisation, custody, or a motivated attempt to stop, tolerance drops within days to weeks, and a return to heroin at a previous dose can be fatal. Mixing heroin with alcohol, benzodiazepines, or other central nervous system depressants compounds respiratory depression unpredictably. Street heroin contaminated with fentanyl dramatically increases overdose risk because fentanyl is 50 to 100 times more potent than morphine, a pattern the CDC's overview of opioid overdose documents in detail.

Rapid access to medical support changes outcomes in these situations. Jintara's small residential setting in Chiang Mai means nursing staff can respond to any medical event within minutes, with escalation pathways to partner hospitals for any situation that requires emergency intervention. The nursing team is trained to recognise the early signs of respiratory depression before they become a crisis.